BioAesthetics Appoints Juliana Blum, PhD, as New CEO
Slice of Healthcare Team
Aug 30, 2024
Key Highlights
- Juliana Blum, PhD, named CEO of BioAesthetics, effective August 12, 2024.
- Blum brings 20 years of biotech experience, notably as Co-founder of Humacyte.
- Focus on advancing BioAesthetics’ next-gen drug-eluting graft technology for soft tissue reconstruction.
Source: Business Wire
Notable Quotes
“ This is an important milestone for BioAesthetics... Dr. Blum’s experience with novel products as co-founder of Humacyte will help guide further progress at BioAesthetics. ”
Dr. Sandra Coufal, MD, Director of BioAesthetics and CEO at Toragen, Inc
“ I am thrilled to join the BioAesthetics team... There is a strong foundation for future growth and innovation around this novel platform that I look forward to leading. ”
Dr. Juliana Blum, CEO at BioAesthetics
“ Dr. Blum has a proven reputation for developing and managing partnerships... This experience is critical for the future growth of BioAesthetics. ”
Joseph Nixon, MBA, Director of BioAesthetics and CFO at Locus Biosciences, Inc
